Concepedia

Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study

Florelle Bellet, Marie‐Noëlle Beyens, Nathalie Bernard, Delphine Beghin, Élisabeth Éléfant, Thierry Vial

Pharmacoepidemiology and Drug Safety · 2015 · 57 citations · 14 references

Abstract

This study failed to demonstrate a significant association between aripiprazole exposure during the embryonic period and major malformations. More powerful prospective studies are required to clarify the reproductive safety profile of aripiprazole.

References

14

Guidelines for case classification for the national birth defects prevention study

Sonja A. Rasmussen, Richard S. Olney, Lewis B. Holmes et al. · Birth Defects Research Part A Clinical and Molecular Teratology · 2003 · 571 citations

Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice

Christopher Everett · BMJ · 1997 · 405 citations · Full text

Pregnancy Outcome of Women Using Atypical Antipsychotic Drugs

Kate McKenna, Gideon Koren, Maria Tetelbaum et al. · The Journal of Clinical Psychiatry · 2005 · 313 citations

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study

Lars Henning Pedersen, Tore Henriksen, Mogens Vestergaard et al. · BMJ · 2009 · 297 citations · Full text

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population‐based health data

Tim F. Oberlander, William Warburton, Shaila Misri et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 2008 · 188 citations · Full text